£91.54

Nova Science Publishers Inc Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£92 today · all-time low £88 (Aug 2026) · usually £90

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days · 90 data points

Historical
Generating forecast…
£91.56 £87.94 £88.73 £89.52 £90.31 £91.10 £91.89 09 July 2026 31 July 2026 22 August 2026 13 September 2026 06 October 2026

Price Distribution

Price distribution over 90 days • 4 price levels

Days at Price
Current Price
12 days 56 days 17 days 5 days · current 0 14 28 42 56 £88 £90 £91 £92 Days at Price

Price Analysis

Most common price: £90 (56 days, 62.2%)

Price range: £88 - £92

Price levels: 4 different prices over 90 days

Description

Bladder cancer is the fifth most common form of cancer worldwide and is mainly prevalent in developed countries. It is thought to arise through two distinct pathways: the noninvasive and the invasive. The noninvasive pathway gives rise to a superficial papillary carcinoma that is characterized by activating mutations in oncogenes such as H-ras, FGFR3 and PI3K. This pathway is rarely lethal as superficial papillary carcinomas can be readily removed through transurethral resection. However, 15% of noninvasive urothelial tumors can transform into invasive carcinomas and have high recurrence (80% of the cases) that requires intensive surveillance and repetitive treatment. This book discusses the risk factors of bladder cancer, as well as the emerging treatment strategies and challenges.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Advances in the Scientific Evaluation of Bladder Cancer and Molecular Basis for Diagnosis and Treatment
98% match

Advances in the Scientific Evaluation of Bladder Cancer and Molecular Basis for Diagnosis and Treatment

IntechOpen

£119.00 05 Oct 2026
Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care
98% match

Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care

Elsevier

£119.36 24 Sep 2026
Metabolomics of Bladder Cancer: An Emerging Application
97% match

Metabolomics of Bladder Cancer: An Emerging Application

Elsevier

£130.56 03 Oct 2026
Bladder Cancer: Etymology, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)
97% match

Bladder Cancer: Etymology, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

£141.66 24 Sep 2026
Update on Bladder Cancer
97% match

Update on Bladder Cancer

IntechOpen

£100.00 22 Sep 2026
Bladder Cancer: Research Advances and Clinical Challenges (Cancer Etiology, Diagnosis and Treatments)
97% match

Bladder Cancer: Research Advances and Clinical Challenges (Cancer Etiology, Diagnosis and Treatments)

£203.99 22 Aug 2026
Biology of Bladder Cancer: From Molecular Insights to Clinical Strategies
97% match

Biology of Bladder Cancer: From Molecular Insights to Clinical Strategies

Springer

£82.01 06 Oct 2026
Current Management of Superficial Bladder Cancer, An Issue of Urologic Clinics of North America: Volume 53-3 (The Clinics: Surgery, Volume 53-3)
97% match

Current Management of Superficial Bladder Cancer, An Issue of Urologic Clinics of North America: Volume 53-3 (The Clinics: Surgery, Volume 53-3)

Elsevier

£85.99 26 Sep 2026
Treating Urothelial Bladder Cancer
96% match

Treating Urothelial Bladder Cancer

Springer

£74.56 03 Oct 2026
A Guide to Management of Urological Cancers
96% match

A Guide to Management of Urological Cancers

Springer

£87.94 03 Oct 2026
Guide to Management of Urological Cancers - Springer
96% match

Guide to Management of Urological Cancers - Springer

Springer

£114.95 06 Oct 2026
Springer - Prostate Cancer: Pathogenesis, Diagnosis, Therapy
96% match

Springer - Prostate Cancer: Pathogenesis, Diagnosis, Therapy

Springer

£121.46 27 Jul 2026
Methylation of APC tumor suppressor gene in bladder cancer: Molecular Screening for Bladder Cancer project. PI: Prof.Sanaa Eissa, medical biochemistry & molecular biology dept.
96% match

Methylation of APC tumor suppressor gene in bladder cancer: Molecular Screening for Bladder Cancer project. PI: Prof.Sanaa Eissa, medical biochemistry & molecular biology dept.

LAP Lambert Academic Publishing

£66.00 31 Jul 2026
Textbook of Bladder Cancer
96% match

Textbook of Bladder Cancer

CRC Press

£119.99 25 Sep 2026
Clinical Urology
96% match

Clinical Urology

Foster Academics

£75.67 23 Sep 2026
Female Sex Hormones & Cancers (Cancer Etiology, Diagnosis & Treatments Series)
96% match

Female Sex Hormones & Cancers (Cancer Etiology, Diagnosis & Treatments Series)

£155.48 12 Aug 2026
Urologie essentials: Intensivkurs zur Weiterbildung
96% match

Urologie essentials: Intensivkurs zur Weiterbildung

Thieme

Price unavailable
Prostate Cancer, Sexual Health, and Ageing Masculinities: Exploring the Achilles' Heel of Men
96% match

Prostate Cancer, Sexual Health, and Ageing Masculinities: Exploring the Achilles' Heel of Men

Palgrave

£80.65 23 Sep 2026
Urological Cancer 2022
96% match

Urological Cancer 2022

£58.09 06 Sep 2026
The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan
96% match

The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan

£595.00 28 Aug 2026
Current Therapeutic Strategies for Cancer Management - Medical Reference
96% match

Current Therapeutic Strategies for Cancer Management - Medical Reference

£133.64 05 Oct 2026
Urologic Cancer: Chemotherapeutic Principles and Management: Chemotherapeutic Principles and Management: 85 (Recent Results in Cancer Research)
96% match

Urologic Cancer: Chemotherapeutic Principles and Management: Chemotherapeutic Principles and Management: 85 (Recent Results in Cancer Research)

Springer

£82.93 02 Oct 2026
Prognostic & Predictive Response Therapy Factors in Cancer Disease: Colorectal, Breast, Liver, Lung, Gastric, Renal & Prostate Cancers (Cancer Etiology, Diagnosis and Treatments)
96% match

Prognostic & Predictive Response Therapy Factors in Cancer Disease: Colorectal, Breast, Liver, Lung, Gastric, Renal & Prostate Cancers (Cancer Etiology, Diagnosis and Treatments)

Nova Science Publishers Inc

£57.59 22 Sep 2026
Therapy Resistance in Prostate Cancer - Volume 20 Mechanisms
96% match

Therapy Resistance in Prostate Cancer - Volume 20 Mechanisms

Elsevier

£115.57 06 Oct 2026